EXPLORE!

What is MPGN? New Ventures

  952 Views

Dr Giuseppe Remuzzi, Italy    12 January 2018

  1. Patients with C3G/IC-MPGN assigned to specific clusters facilitate clarification of disease etiology; improve risk assessment for ESRD, and pave the way for personalized treatment (Iatropoulos P, et al. JASN. 2017).
  2. Most importantly, their cluster analysis did better at predicting renal survival than the division into MPGN, DD and C3GN (Cook HT, et al.J Am Soc Nephrol. 2017).
  3. Rituximab, at a dose that completely depleted CD19+ B cells, reduced the C3NeF titer but had no effect on proteinuria, serum protein levels and renal function.
  4. Chronic administration of eculizumab-induced partial remission of nephrotic syndrome, ameliorated renal function and did not affect C3.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.